Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System - BioSpace

Vesper Medical Announces $37 Million Financing with Vensana Capital and Gilde Healthcare to Complete Development of Its Duo Venous Stent System  BioSpace

WAYNE, Pa.--(BUSINESS WIRE)-- Vesper Medical, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today ...